Considering the important role of AAT in modulation of inflammation, as well as the recent beneficial effect of human AAT against bacterial infections [45], hAAT could represent a potential novel adjuvant immunotherapy against systemic Candida infection. Here, SERPINA1 is linked to candidiasis.